Stage IIIC Uterine Corpus Carcinoma or Carcinosarcoma by AJCC v7 Stage
1 clinical trials · Condition
◉ Watch Stage IIIC Uterine Corpus Carcinoma or Carcinosarcoma by AJCC v7 Stage
| Record | Firm | Date |
|---|---|---|
| Paclitaxel, Carboplatin, and Bevacizumab or Paclitaxel, Carboplatin, and Temsirolimus or Ixabepilone, Carboplatin, and Bevacizumab in Treating Patients With Stage III, Stage IV, or Recurrent Endometrial Cancer (NCT00977574) | National Cancer Institute (NCI) | 2009-09-14 |
Track Stage IIIC Uterine Corpus Carcinoma or Carcinosarcoma by AJCC v7 Stage automatically
Every clearance here is in the API, with alerts when new ones post.